|
In-licensing/Out-Licensing Strategies and Practices –
April 2009; Vol. 4 No. 2
Pharmaceutical firms looking to license new drug candidates from other firms will improve their chances of achieving a successful alliance if they focus on building a relationship, not just acquiring an asset.
“While there is no single approach to licensing, senior managers in the research based drug industry understand that the factors defining success in drug development are rapidly changing. For example, developing a product considered best or first in its class is becoming secondary to marketing exclusivity, which may do more to drive revenue.”
|
